Park Avenue Securities’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
WA
Park Avenue Securities's MEDP Position: Q2 2026 in Review
Park Avenue Securities increased its Medpace (MEDP) stake by 1.1% in Q2 2026, buying an estimated $11.5K and bringing the position to 2,395 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #849.
Park Avenue Securities first reported a position in MEDP in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.63M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Park Avenue Securities held 2,395 shares of Medpace worth $1.27M as of Q2 2026.
- Park Avenue Securities bought 25 Medpace shares in Q2 2026, an estimated $11.5K.
- Medpace made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #849 holding.
- Park Avenue Securities first reported a position in Medpace in Q2 2020 and has held it in 21 quarters since.
- Park Avenue Securities's Medpace position peaked at $1.63M in Q4 2025.
- 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.